UPL [UPLPP] vs Bayer CropScience [BAYERCROP] Detailed Stock Comparison
UPL
BSE
Loading...
Bayer CropScience
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: UPL wins in 11 metrics, Bayer CropScience wins in 8 metrics, with 0 ties. UPL appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | UPL | Bayer CropScience | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 3.00 | 43.07 | UPL |
| Price-to-Book Ratio | 1.63 | 8.95 | UPL |
| Debt-to-Equity Ratio | 105.06 | 3.69 | Bayer CropScience |
| PEG Ratio | -0.02 | N/A | N/A |
| EV/EBITDA | 13.32 | 40.81 | UPL |
| Profit Margin (TTM) | 0.09% | 10.38% | Bayer CropScience |
| Operating Margin (TTM) | 13.51% | 13.34% | UPL |
| EBITDA Margin (TTM) | 13.51% | 13.34% | UPL |
| Return on Equity | 2.01% | 19.93% | Bayer CropScience |
| Return on Assets (TTM) | 0.86% | 7.71% | Bayer CropScience |
| Free Cash Flow (TTM) | $84.56B | $2.21B | UPL |
| Dividend Yield | 0.69% | 2.20% | Bayer CropScience |
| 1-Year Return | 104.96% | -13.96% | UPL |
| Price-to-Sales Ratio (TTM) | 1.38 | 4.87 | UPL |
| Enterprise Value | $724.61B | $262.35B | UPL |
| EV/Revenue Ratio | 1.61 | 4.79 | UPL |
| Gross Profit Margin (TTM) | 54.76% | 46.16% | UPL |
| Revenue per Share (TTM) | $570 | $1,218 | Bayer CropScience |
| Earnings per Share (Diluted) | $-0.74 | $131.82 | Bayer CropScience |
| Beta (Stock Volatility) | 0.83 | 0.32 | Bayer CropScience |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
UPL vs Bayer CropScience Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| UPL | 0.00% | 0.00% | 14.98% | 19.23% | 96.43% | 129.00% |
| Bayer CropScience | -1.88% | -10.90% | -14.04% | 20.76% | 14.62% | 0.80% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| UPL | 104.96% | 104.96% | 104.96% | 104.96% | 104.96% | 104.96% |
| Bayer CropScience | -13.96% | 4.96% | -6.43% | 44.06% | 484.98% | 921.50% |
Performance & Financial Health Analysis: UPL vs Bayer CropScience
| Metric | UPLPP | BAYERCROP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹622.77B | ₹266.70B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 10,679 | 57,358 |
| 90 Day Avg. Volume | 6,755 | 54,626 |
| Last Close | ₹516.50 | ₹5,572.50 |
| 52 Week Range | ₹216.20 - ₹563.85 | ₹4,217.45 - ₹7,196.85 |
| % from 52W High | -8.40% | -22.57% |
| All-Time High | ₹563.85 (Jul 30, 2025) | ₹7,196.85 (Aug 05, 2024) |
| % from All-Time High | -8.40% | -22.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.32% |
| Quarterly Earnings Growth | 0.02% | 0.49% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.10% |
| Operating Margin (TTM) | 0.14% | 0.13% |
| Return on Equity (TTM) | 0.02% | 0.20% |
| Debt to Equity (MRQ) | 105.06 | 3.69 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹318.92 | ₹634.24 |
| Cash per Share (MRQ) | ₹51.99 | ₹204.91 |
| Operating Cash Flow (TTM) | ₹70.93B | ₹2.62B |
| Levered Free Cash Flow (TTM) | ₹7.59B | ₹1.66B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.69% | 2.20% |
| Last 12-Month Dividend | ₹3.00 | ₹125.00 |
Valuation & Enterprise Metrics Analysis: UPL vs Bayer CropScience
| Metric | UPLPP | BAYERCROP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 3.00 | 43.07 |
| Forward P/E | N/A | 28.54 |
| PEG Ratio | -0.02 | N/A |
| Price to Sales (TTM) | 1.38 | 4.87 |
| Price to Book (MRQ) | 1.63 | 8.95 |
| Market Capitalization | ||
| Market Capitalization | ₹622.77B | ₹266.70B |
| Enterprise Value | ₹724.61B | ₹262.35B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.61 | 4.79 |
| Enterprise to EBITDA | 13.32 | 40.81 |
| Risk & Other Metrics | ||
| Beta | 0.83 | 0.32 |
| Book Value per Share (MRQ) | ₹318.92 | ₹634.24 |
Financial Statements Comparison: UPL vs Bayer CropScience
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | UPLPP | BAYERCROP |
|---|---|---|
| Revenue/Sales | ₹92.16B | ₹10.48B |
| Cost of Goods Sold | ₹41.69B | ₹5.64B |
| Gross Profit | ₹50.47B | ₹4.84B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹7.64B | ₹1.38B |
| EBITDA | ₹14.78B | ₹2.08B |
| Pre-Tax Income | ₹-1.90B | ₹1.68B |
| Income Tax | ₹-140.00M | ₹246.00M |
| Net Income (Profit) | ₹-1.76B | ₹1.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | UPLPP | BAYERCROP |
|---|---|---|
| Cash & Equivalents | ₹94.78B | ₹8.86B |
| Total Current Assets | ₹396.61B | ₹44.72B |
| Total Current Liabilities | ₹285.69B | ₹22.24B |
| Long-Term Debt | ₹192.56B | ₹616.00M |
| Total Shareholders Equity | ₹378.26B | ₹28.50B |
| Retained Earnings | ₹208.68B | N/A |
| Property, Plant & Equipment | ₹94.31B | ₹4.27B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | UPLPP | BAYERCROP |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | UPLPP | BAYERCROP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,679 | 57,358 |
| Average Daily Volume (90 Day) | 6,755 | 54,626 |
| Shares Outstanding | 844.43M | 44.94M |
| Float Shares | 563.84M | 19.00M |
| % Held by Insiders | 0.00% | 0.73% |
| % Held by Institutions | 0.17% | 0.12% |
Dividend Analysis & Yield Comparison: UPL vs Bayer CropScience
| Metric | UPLPP | BAYERCROP |
|---|---|---|
| Last 12-Month Dividend | ₹3.00 | ₹125.00 |
| Last 12-Month Dividend Yield | 0.69% | 2.20% |
| 3-Year Avg Annual Dividend | ₹1.00 | ₹141.67 |
| 3-Year Avg Dividend Yield | 0.69% | 1.16% |
| 3-Year Total Dividends | ₹3.00 | ₹425.00 |
| Ex-Dividend Date | Jul 11, 2025 | Aug 07, 2025 |